Skip to main content

Perspective Therapeutics Inc

For the period ended Sep 30, 2024. Filed Nov 12, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 12, 2024

CATX$0.84+6.5%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

PART I · FINANCIAL INFORMATION
Item 1Financial Statements1
Condensed Consolidated Balance Sheets as of September 30, 2024 (unaudited) and December 31, 20231
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023 (unaudited)2
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023 (unaudited)3
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the three and nine months ended September 30, 2024 and 2023 (unaudited)4
Notes to the Unaudited Condensed Consolidated Financial Statements5
Item 2Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3Quantitative and Qualitative Disclosures About Market Risk29
Item 4Controls and Procedures29
PART IIOTHER INFORMATION
Item 1Legal Proceedings30
Item 1ARisk Factors30
Item 2Unregistered Sales of Equity Securities and Use of Proceeds30
Item 3Defaults Upon Senior Securities30
Item 4Mine Safety Disclosures30
Item 5Other Information31
Item 6Exhibits32
Signatures33

iii

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.